Completed
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
NCT02603705
- Conditions
- Chronic Pain, Moderate-to-severe Chronic Noncancer Pain, Neurologic Manifestations, +3 more
- Locations
-
- Site 334 Huntsville, Alabama, United States
- Site 328 Tucson, Arizona, United States
- Site 332 Jacksonville, Florida, United States
- Site 340 Miami Gardens, Florida, United States